Dr. Byung-Wook Kim | Nanomaterials | Best Researcher Award

Posted on by ScienceFather

Dr. Byung-Wook Kim | Nanomaterials | Best Researcher Award

Dr. Byung-Wook Kim, Columbia University, United States

Dr. Byung-Wook Kim is an Associate Research Scientist at Columbia University, specializing in nanomaterials, energy harvesting, and thermal management. With a Ph.D. in Materials Science & Engineering from UCSD 🎓, his work focuses on advanced materials for thermal and electrical applications. Previously, he was a Senior Research Engineer at Hyundai Motor Company 🚗, where he contributed to energy-efficient automotive materials. Dr. Kim has received prestigious awards 🏆 and has published extensively in high-impact journals. His collaborations with Columbia Nano Initiative and leading researchers drive advancements in radiative cooling, thermoelectrics, and polymer nanocomposites.

Professional Profile:

Orcid

Suitability of Dr. Byung-Wook Kim for the Best Researcher Award 🏆

Dr. Byung-Wook Kim is a leading researcher in nanomaterials, energy harvesting, and thermal management, making groundbreaking contributions to radiative cooling, thermoelectrics, and polymer nanocomposites. His expertise spans both academia and industry, with notable contributions at Columbia University and Hyundai Motor Company. His high-impact publications, prestigious awards, and pioneering research in sustainable energy solutions position him as a strong candidate for the Best Researcher Award.

Education & Experience 🎓👨‍🔬

  • Ph.D. in Materials Science & Engineering – University of California, San Diego (UCSD) 🏛️

  • M.S. in Applied Physics – University of California, San Diego (UCSD) ⚛️

  • B.S. in Physics – Hanyang University, Seoul 🇰🇷

  • Associate Research Scientist – Columbia University 🏢

  • Senior Research Engineer – Hyundai Motor Company 🚘

  • Postdoctoral Researcher – Advanced materials and energy systems 🔬

Professional Development 🚀

Dr. Byung-Wook Kim has been at the forefront of nanomaterials, energy storage, and thermoelectric technology. His expertise extends to radiative cooling, polymer composites, and photonic structures, enhancing energy efficiency across multiple sectors. At Columbia University, he collaborates with top researchers on breakthrough materials. His industrial experience at Hyundai Motor Company helped develop high-performance energy solutions for automotive applications. A dedicated researcher, Dr. Kim actively participates in Columbia Nano Initiative and energy research centers. With numerous high-impact publications and awards, he remains a key contributor to advancing sustainable and efficient energy technologies 🌍🔋.

Research Focus 🔬

Dr. Byung-Wook Kim’s research primarily revolves around nanomaterials, thermal management, and energy harvesting. His work explores carbon nanotube-polymer composites for enhanced electrical and thermal conductivity, as well as radiative cooling materials to improve energy efficiency ☀️❄️. He is also involved in developing thermoelectric materials that convert waste heat into usable energy ⚡. His contributions extend to photonic structures, advanced composites, and sustainable energy storage solutions. At Columbia University, he collaborates on next-generation energy systems, pushing the boundaries of nanotechnology and applied physics for real-world applications in clean energy and thermal regulation 🌱🔋.

Awards & Honors 🏆🎖️

  • 🏅 Nanoscale Horizons Outstanding Paper Award (2023) – Recognized for excellence in nanomaterials research
  • 🏆 Excellence in Advanced Technology (2019) – Hyundai Motor Company, for contributions to advanced energy-efficient materials
  • 📜 Multiple High-Impact Publications – Featured in Light: Science & Applications, Journal of Applied Physics, Nanomaterials
  • 🎓 Research Grants & Fellowships – Funding for cutting-edge energy and materials research
  • 🔬 Columbia Nano Initiative Affiliation – Recognized researcher in advanced materials and nanotechnology

Publication Top Notes:

  • 🏭 Abrasion Effect on Heating Performance of Carbon Nanotube/Epoxy Composites
  • 🌱 Bio-Based Phase Change Materials for Sustainable Development
  • 📏 Thermoelastic Modeling of Cubic Lattices from Granular Materials to Atomic Crystals
  • ⚡ An Ag–Au-PANI Core–Shell Nanowire Network for Visible-to-Infrared Data Encryption and Supercapacitor Applications
  • ☀️ Photonic Structures in Radiative Cooling

 

Mustafa Arslan | Nanomedicine | Best Researcher Award

Posted on by ScienceFather

Prof. Dr. Mustafa Arslan | Nanomedicine | Best Researcher Award

Prof. Dr. at Gazi University, Medical Faculty, Turkey.

Prof. Mustafa Arslan is a distinguished medical researcher and professor at Gazi University, specializing in surgery and fundamental medical sciences. With a career spanning over two decades, he has made significant contributions to medical research, particularly in experimental and clinical studies. As the Director of the Experimental and Clinical Research Center at Gazi University, he has played a crucial role in advancing surgical and anesthesia-related research. His extensive academic involvement includes serving on multiple ethics committees, supervising research projects, and mentoring doctoral students. Prof. Arslan has published widely in high-impact medical journals and is recognized for his expertise in ischemia-reperfusion injury models. His active participation in academic and administrative roles highlights his leadership in medical sciences. With a strong presence in international research databases such as Scopus, Web of Science, and Google Scholar, he has established himself as a key figure in medical research. His dedication to medical education, research ethics, and innovative surgical techniques positions him as a leading expert in his field. Prof. Arslan continues to contribute significantly to medical advancements through his research, teaching, and leadership, making him a highly respected figure in the global medical community.

Professional Profile:

Education

Prof. Mustafa Arslan has an extensive educational background in medicine, reflecting his commitment to academic excellence and medical research. He earned his undergraduate degree from Ege University, Faculty of Medicine, in 1994, laying a strong foundation for his future career in surgery and medical sciences. He then pursued an advanced specialization in medicine at Erciyes University, where he focused on fundamental medical sciences from 1999 to 2001. Continuing his academic journey, he obtained further expertise in surgery from Gazi University’s Faculty of Medicine between 2001 and 2006. His dissertation research at Gazi University focused on the comparative effects of desflurane and sevoflurane on rat liver, emphasizing gender and age-related differences. Additionally, his earlier research at Erciyes University explored electrophysiological and electrodermal activity changes in Behçet’s disease, demonstrating his interdisciplinary approach to medicine. Prof. Arslan has also undertaken specialized training in experimental animal research, completing certification in laboratory animal studies at Erciyes University in 2003. His continuous pursuit of knowledge and specialization in surgical and experimental medicine has shaped his career as a researcher and educator, enabling him to contribute significantly to medical sciences through innovative research and clinical advancements.

Professional Experience

Prof. Mustafa Arslan has built an impressive professional career, marked by significant roles in academia, research, and medical administration. Since 2021, he has been serving as a Professor in the Department of Surgical Medical Sciences at Gazi University, where he leads innovative research in experimental medicine and surgery. His administrative contributions include his role as the Director of the Experimental and Clinical Research Center at Gazi University since 2022, where he oversees advanced medical studies and laboratory experiments. He also chairs the Experimental Animals Ethics Committee, ensuring ethical compliance in medical research. Additionally, Prof. Arslan has been an Assistant Manager at the Research and Application Center at Gazi University since 2020, playing a key role in promoting interdisciplinary research collaborations. His long-standing membership on various ethics and academic committees at Gazi University further underscores his influence in shaping research policies and medical education. Over the years, he has supervised numerous doctoral dissertations, conducted specialized courses in anesthesia and systemic diseases, and participated in faculty governance. His vast experience in experimental and clinical medicine, combined with his leadership in medical education, makes him a distinguished figure in academic and medical circles.

Research Interest

Prof. Mustafa Arslan’s research interests span across various domains of medical and surgical sciences, with a particular focus on experimental medicine, anesthesiology, and ischemia-reperfusion injury models. His work in anesthesia research has explored the effects of different anesthetic agents on organ function, particularly in the context of liver and cardiovascular health. He has also conducted in-depth studies on systemic diseases and their impact on surgical outcomes. His research in ischemia-reperfusion injury has led to new insights into the mechanisms of cellular damage and potential therapeutic interventions. Prof. Arslan is also deeply interested in the ethical and methodological aspects of experimental research, leading various committees to ensure high standards in medical investigations. His expertise extends to the use of experimental animal models in medical research, where he has contributed to advancing surgical techniques and improving post-operative care. He remains committed to interdisciplinary research, collaborating with experts in pharmacology, physiology, and biomedical engineering to develop innovative medical solutions. Through his research, he aims to improve surgical outcomes, enhance patient safety, and contribute to the development of novel medical treatments and technologies.

Research Skills

Prof. Mustafa Arslan possesses a diverse set of research skills that make him a leader in medical and surgical sciences. His expertise in experimental research methodologies allows him to design and execute complex studies involving animal models and clinical trials. He is proficient in advanced surgical techniques, particularly in the study of ischemia-reperfusion injuries and anesthesia-related complications. His skills in electrophysiological assessments and biomedical instrumentation enable him to conduct high-precision studies on systemic diseases and their effects on the human body. Prof. Arslan is also well-versed in statistical analysis and research data interpretation, ensuring the accuracy and reliability of his findings. His experience in research ethics and laboratory management has equipped him with the ability to oversee large-scale experimental projects while maintaining compliance with ethical guidelines. Additionally, he has strong mentorship and academic writing skills, having supervised multiple doctoral theses and published extensively in peer-reviewed journals. His ability to integrate medical research with technological advancements makes him a valuable contributor to modern medical science.

Awards and Honors

Throughout his career, Prof. Mustafa Arslan has received numerous accolades in recognition of his contributions to medical research and education. His outstanding research achievements have earned him multiple institutional awards at Gazi University, where he has been recognized for his excellence in experimental and clinical medicine. His role in ethical research and academic governance has also been acknowledged through his appointments to key committee positions, demonstrating the trust placed in him by his peers. Additionally, his active participation in academic conferences, jury memberships, and doctoral supervision has been instrumental in shaping medical education and research in Turkey. Prof. Arslan’s contributions to anesthesia and ischemia-reperfusion injury research have gained significant recognition, positioning him as an influential figure in his field. His commitment to ethical research practices and continuous academic development further underscores his reputation as a dedicated researcher and educator. While his achievements are already substantial, his ongoing research and contributions to medical sciences suggest that more prestigious honors await him in the future.

Conclusion

Prof. Mustafa Arslan is a highly accomplished researcher, educator, and medical professional whose contributions to surgical and experimental medicine have had a profound impact. His expertise in anesthesia, ischemia-reperfusion injury models, and systemic disease research, combined with his leadership in medical ethics and experimental research, positions him as a leading figure in medical sciences. His extensive academic and administrative experience at Gazi University, along with his mentorship of future medical researchers, highlights his dedication to advancing medical knowledge and improving patient outcomes. His strong research skills, ethical leadership, and commitment to interdisciplinary collaboration make him a deserving candidate for prestigious research awards. While he has already earned significant recognition, expanding his international collaborations and securing more research grants could further enhance his global impact. Overall, Prof. Arslan’s remarkable career and contributions to medical research solidify his reputation as an outstanding scientist and educator in the field of medicine.

Publication Top Notes

  • Effects of Pomegranate Seed Oil on Lower Extremity Ischemia-Reperfusion Damage: Insights into Oxidative Stress, Inflammation, and Cell Death
    📌 Medicina, 2025-01-24 | DOI: 10.3390/medicina61020212
    Contributors: Ümmü Gülşen Bozok, Aydan İremnur Ergörün, Ayşegül Küçük, Zeynep Yığman, Ali Doğan Dursun, Mustafa Arslan
  • Effects of Cerium Oxide on Kidney and Liver Tissue Damage in an Experimental Myocardial Ischemia-Reperfusion Model of Distant Organ Damage
    📌 Medicina, 2024-12-11 | DOI: 10.3390/medicina60122044
    Contributors: Işın Güneş, Ali Doğan Dursun, Çağrı Özdemir, Ayşegül Küçük, Şaban Cem Sezen, Mustafa Arslan, Abdullah Özer
  • The Effect of Silymarin on Ischemia-Reperfusion Injury in Skeletal Muscles of Rats
    📌 Turkish Journal of Vascular Surgery, 2024-11-15 | DOI: 10.9739/tjvs.2024.09.038
    Contributors: Abdullah Ozer, Basak Kocak, Mustafa Arslan, Baris Mardin, Aysegul Kucuk, Saban Cem Sezen, Mustafa Hakan Zor, Mustafa Kavutcu
  • Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model
    📌 Drug Design, Development and Therapy, 2024-09 | DOI: 10.2147/DDDT.S482309
    Contributors: Mehmet Gülcan, Hüseyin Demirtaş, Abdullah Özer, Zeynep Yığman, Ali Dursun, Mustafa Arslan, Gürsel Oktar
  • Evaluation of the Efficacy of Ozone Therapy on Liver Tissue in the Treatment of Sepsis in Rats with Cecal Perforation
    📌 Medicina, 2024-09-22 | DOI: 10.3390/medicina60091552
    Contributors: Selin Erel, Ayşegül Küçükk, Kürşat Dikmen, Esin Tekin, Zeynep Yığman, Müşerref Şeyma Ceyhan, Seda Gökgöz, Hasan Bostancı, Mustafa Arslan, Mustafa Kavutcu

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Posted on by ScienceFather

Ms. Moloud Farrokhi | Nanodelivery Awards | Best Researcher Award

Ms. Moloud Farrokhi , Albany Medical college, United States

Mouloud Farrokhi is an experienced immunologist and microbiologist specializing in HIV/AIDS research, nanoparticle delivery systems, and viral infections. He is currently pursuing a PhD in Biology with a focus on Immunology and Microbiology at Albany Medical College, USA. Mouloud has a strong academic and professional background, having worked as a research assistant and medical laboratory scientist in Iran and Sweden. His research aims to improve understanding and treatment of viral infections, with significant contributions to HIV drug resistance and oncolytic virus therapy. Mouloud’s work also extends to the development of innovative nanoparticle-based drug delivery systems, offering promising solutions for invasive infections like Aspergillosis. His expertise spans from molecular biology to clinical research, with an emphasis on laboratory techniques like PCR, qRT-PCR, NGS, and CRISPR/Cas9.

Professional Profile:

Google Scholar

Mouloud Farrokhi: A Strong Contender for the Research Best Researcher Award

Mouloud Farrokhi is an exceptional candidate for the Research Best Researcher Award due to his extensive background in immunology, microbiology, and viral infections, as well as his significant contributions to molecular diagnostics and therapeutic innovations. His educational qualifications, research experience, and recognition in the field of medical sciences make him a highly suitable candidate for this prestigious award.

🎓Education:

Mouloud Farrokhi is currently pursuing a PhD in Biology, specializing in Immunology and Microbiology at Albany Medical College, USA (2023–Present). He holds two Master’s degrees: an MSc in Bioscience from the University of Skövde, Sweden (2021–2022), with a thesis on the role of RABL6 in AP3-dependent trafficking, and an MSc in Cellular and Molecular Biology from the Islamic Azad University, Iran (2010–2014), where he researched HIV-1 drug resistance. His undergraduate studies were in Marine Biology at the Islamic Azad University, Tehran, Iran (2003–2008). Mouloud’s extensive education in biological sciences provides a solid foundation for his current research endeavors, focusing on viral infections, molecular diagnostics, and therapeutic innovations.

🏢Experience:

Mouloud Farrokhi has gained extensive experience as a research assistant and medical laboratory scientist. He worked as a Research Assistant at Tehran University of Medical Sciences (2022–2023), where he focused on statistical analysis and NGS (Next Generation Sequencing). He has also served as a Medical Laboratory Assistant at Tehran University of Medical Sciences (2018–2021), where he conducted HIV viral load analysis and COVID-19 testing via qPCR. His previous roles include being a Medical Laboratory Scientist at Dena Lab (2017–2018), where he performed NITP tests and a Research Assistant at Pasteur Institute of Iran (2016–2017), where he researched drug resistance in HIV and HCV. He has also contributed to laboratory work at Keyvan Virology Laboratory, Tehran (2015–2016). Mouloud’s diverse hands-on experience makes him proficient in molecular biology techniques, data analysis, and lab management.

🏅Awards and Honors:

Mouloud Farrokhi’s academic and research achievements are reflected in his high academic standing and contributions to scientific research. His thesis at the University of Skövde received top marks, with a GPA of 3.75, and he has consistently demonstrated excellence throughout his academic career. His research contributions have been recognized in various publications and presentations. Notably, he presented at the International Student Congress in Medical Sciences (ISCOM) in 2017 and at the Upstate New York Immunology Conference (NYIC) in 2024. Mouloud’s work in HIV drug resistance and nanoparticle drug delivery systems has been published in high-impact journals. His dedication to advancing medical science has led to multiple research opportunities, including participation in workshops on gene transfer and vaccine design.

🔬Research Focus:

Mouloud Farrokhi’s research focuses on immunology, microbiology, and the molecular mechanisms underlying viral infections and drug resistance. He investigates the molecular pathways of HIV and other viral infections, focusing on drug resistance mechanisms in HIV-1 and HCV. His research also explores innovative strategies for oncolytic virus therapy and nanoparticle-based drug delivery, with the goal of improving treatment outcomes for invasive infections like Aspergillosis. Additionally, he is involved in genetic analysis and genomic editing technologies such as CRISPR/Cas9. Mouloud’s work integrates molecular diagnostics and therapeutic advancements, contributing significantly to both basic science and clinical applications in virology and immunology.

Publication Top Notes:

  • “Subtype classification of Iranian HIV-1 sequences registered in the HIV databases, 2006-2013”
    • Citations: 31
  • “HIV drug resistance among naïve HIV-infected patients in Iran”
    • Citations: 14
  • “Antiretroviral drug resistance mutations among HIV treatment failure patients in Tehran, Iran”
    • Citations: 11
  • “The first characterization of HIV-1 subtypes and drug resistance mutations among antiretrovirally treated patients in Kermanshah, Iran”
    • Citations: 9
  • “HIV drug resistance and phylogeny profile in naive and antiretroviral-experienced patients in Tehran, Iran”
    • Citations: 8

 

 

 

Dr. Daniel Daneshvar | Nanotherapy Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Daniel Daneshvar | Nanotherapy Awards | Best Researcher Award

Dr. Daniel Daneshvar, Harvard Medical School, United States

Dr. Daniel Hamed Daneshvar is an Assistant Professor of Physical Medicine and Rehabilitation at Harvard Medical School and an active staff member at Spaulding Rehabilitation. He completed his M.D./Ph.D. in Behavioral Neuroscience at Boston University School of Medicine, followed by a residency at Stanford University. Dr. Daneshvar’s expertise lies in brain injury rehabilitation, and he currently serves as the Chief of Brain Injury Rehabilitation at Spaulding. He is also Vice President of the Medical Staff and Director of Training at the Rehabilitation Outcomes Center. Dr. Daneshvar is recognized for his contributions to traumatic brain injury research, leadership in concussion advocacy, and dedication to public health, earning multiple awards, including the 2024 Rising Star Award from the National Neurotrauma Society.

Professional Profile:

Orcid

Suitability for the Best Researcher Award

Dr. Daniel Hamed Daneshvar’s combination of rigorous research, leadership in rehabilitation, and dedication to community service positions him as an outstanding candidate for the Best Researcher Award at the Nanotherapy Awards. His significant contributions to TBI and concussion research, recognized through numerous accolades, coupled with his commitment to mentorship and public health, make him a worthy recipient of this honor. Dr. Daneshvar exemplifies the qualities of an exceptional researcher dedicated to advancing knowledge and improving outcomes in the field of brain injury rehabilitation.

🎓Education:

Dr. Daniel Hamed Daneshvar earned his S.B. in Brain and Cognitive Sciences from the Massachusetts Institute of Technology (MIT) between 2001 and 2005. He later pursued a combined M.D./Ph.D. program in Behavioral Neuroscience at Boston University School of Medicine, completing it from 2007 to 2016. His advanced training in both clinical medicine and neuroscience has shaped his expertise in brain injury rehabilitation and concussion research.

🏢Work Experience:

Dr. Daniel Hamed Daneshvar currently serves as an Assistant Professor of Physical Medicine and Rehabilitation at Harvard Medical School, a position he has held since 2020. In 2023, he became the Chief of Brain Injury Rehabilitation at Spaulding Rehabilitation, where he also holds leadership roles as the Director of Training for the Rehabilitation Outcomes Center (since 2022) and Vice President of the Medical Staff (beginning in 2024). Additionally, Dr. Daneshvar is a Physiatry Consultant for Acute Care Surgery, Trauma, and Surgical Critical Care at Beth Israel Deaconess Medical Center, a role he began in 2023.

🏅Awards:

Dr. Daniel Hamed Daneshvar has been recognized with numerous prestigious awards throughout his career. In 2024, he received both the Rising Star Award from the National Neurotrauma Society and the Teacher of the Year honor at Spaulding Rehabilitation. The previous year, in 2023, he was awarded the Distinguished Research Mentor Award from Spaulding Rehabilitation. In 2022, Dr. Daneshvar was honored with the Claire M. Donaldson Young Investigator Award for his research contributions. Earlier in his career, in 2016, he received the Excellence in Public Health Award from the U.S. Public Health Service Commissioned Corps for his public health efforts.

🔬Research Focus:

Dr. Daneshvar focuses on traumatic brain injury (TBI) rehabilitation, concussion research, and neurological recovery. His work includes advocacy for concussion prevention through the Concussion Legacy Foundation and contributions to national brain injury models. He is also engaged in innovative treatment development for disorders of consciousness and TBI rehabilitation outcomes.

Publication Top Notes:

  • Cognitive, functional, and neuropsychiatric correlates of regional tau pathology in autopsy-confirmed chronic traumatic encephalopathy
  • Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project
  • Relative Contributions of Mixed Pathologies to Cognitive and Functional Symptoms in Brain Donors Exposed to Repetitive Head Impacts
  • Spontaneous Headshake after a Kinematic Event (SHAAKE): Evaluating the Utility of a Potential New Sign in the Diagnosis of Concussion
  • The importance of language in describing concussions: A qualitative analysis

 

 

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Posted on by ScienceFather

Prof. Kang-Ho Choi | Nanotherapy Awards | Best Researcher Award

Prof. Kang-Ho Choi, Chonnam National University Medical School and Hospital, South Korea

Dr. Kang-ho Choi is an esteemed Associate Professor in the Department of Neurology at Chonnam National University Hospital, Gwangju, Korea. He earned his M.D. from Chonnam National University Medical School in 2005, followed by a Ph.D. from the same institution in 2011. Dr. Choi completed extensive postgraduate training, including fellowships at Hanyang University Medical Center and Bristol University. His research and clinical expertise focus on neurology, with notable contributions in stroke and neurodegenerative diseases. Dr. Choi has received numerous awards for his research and clinical excellence, including multiple “Best Investigator” and “Best Poster Presentation” awards. He is a member of various professional organizations, including the Korean Neurological Association and the American Heart Association/American Stroke Association.

Professional Profile:

Scopus

Evaluation of Kangho Choi, M.D., Ph.D. for the Best Researcher Award

Summary of Suitability for Award:

Dr. Kangho Choi is a distinguished researcher in the field of neurology with an impressive track record of achievements that make him a highly suitable candidate for the Best Researcher Award

🎓Education:

Dr. Kang-ho Choi completed his medical education at Chonnam National University Medical School in Gwangju, Korea, where he earned his M.D. degree from March 1999 to February 2005. He continued his academic journey at Chonnam National University Graduate School, obtaining his Master’s degree (M.S.) from March 2006 to February 2008, and later his Ph.D. from March 2009 to February 2011.

🏢Work Experience:

Dr. Kang-ho Choi has held several key positions in his career. Since November 2016, he has been serving as an Associate Professor in the Department of Neurology at Chonnam National University Hospital in Gwangju, Korea. Prior to this role, he was an Assistant Professor in the same department from March 2011 to October 2016. Dr. Choi completed his Clinical Fellowship at Chonnam National University Hospital from March 2010 to February 2011, and also undertook Research Fellowships at Hanyang University Medical Center in Seoul, Korea, from November 2010 to December 2010, and at the School of Clinical Sciences, Bristol University in the United Kingdom, from March 2013 to June 2013. His foundational training includes a Residency in Neurology at Chonnam National University Hospital from March 2006 to February 2010 and a Medical Internship at the same institution from March 2005 to February 2006.

🏅Awards:

Dr. Kang-ho Choi has received numerous prestigious awards throughout his career, reflecting his significant contributions to neurology. He was honored with the Best Investigator Award from Chonnam National University Hospital in December 2019 and May 2022. Additionally, he received the Break-through of the Year award from KHIDI of Korea in December 2017 and from the NRF of Korea in December 2020. In July 2017, he earned the Young Investigator Award at the Hwasun Biomedical Workshop. Dr. Choi’s excellence in research presentations is highlighted by multiple Best Poster Presentation Awards, including those from the ICSU & ICAS Joint Conference in September 2016, the ICSU 2018 & 1st AKJSC Joint Conference in September 2018, Stroke Update 2023 & 11th JKJSC in November 2023, and APSC 2023 in December 2023. His accolades also include the Best Presentation Award at the 35th Conference of KNA in November 2016, the Best Article award at the Annual Meeting of the Korean Neurological Association in October 2009, and the Best Doctor of the Year award from Chonnam National University Hospital in February 2010. Earlier in his career, he was recognized as the Best Resident of the Year by The Korean Intern Resident Association in February 2007.

Publication Top Notes:

  • Focused Magnetic Stimulation for Motor Recovery After Stroke
  • Treatment of Ischemic Stroke by Atorvastatin-Loaded PEGylated Liposome
  • Secular Trends in Outcomes and Impact of Novel Oral Anticoagulants in Atrial Fibrillation-Related Acute Ischemic Stroke
  • Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry
  • Erratum: Corrigendum to “D-dimer to Fibrinogen Ratio Predicts Early Neurological Deterioration in Ischemic Stroke with Atrial Fibrillation”

 

 

 

Assoc Prof Dr. Chong Qiu | Nanomedicine Awards | Young Scientist Award

Posted on by ScienceFather

Assoc Prof Dr. Chong Qiu | Nanomedicine Awards | Young Scientist Award

Assoc Prof Dr. Chong Qiu, China Academy of Chinese Medical Sciences, China

Associate Professor Chong Qiu, Ph.D., is a prominent researcher at the Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing. He earned his bachelor’s and doctoral degrees from the School of Pharmaceutical Science, Peking University, in 2014 and 2019, respectively. Dr. Qiu’s research focuses on advanced nanocarriers for targeted drug delivery, including siRNA and protein delivery systems. He is an active Young Scientist Board Member for several journals and has published extensively, with notable papers in Nature Communications and Journal of Nanobiotechnology. His work has garnered significant attention and impact in the fields of nanomedicine and drug delivery.

Professional Profile:

Orcid

Suitability Summary for Young Scientist Award: Associate Professor Chong Qiu

Associate Professor Chong Qiu is an exemplary candidate for the Young Scientist Award. His pioneering research in nanocarriers for drug delivery, combined with his impressive publication record and leadership roles, highlights his exceptional potential and influence in the scientific community. His achievements and innovative contributions make him a standout nominee for this prestigious award

🎓Education:

Dr. Chong Qiu earned his Ph.D. in Pharmaceutical Sciences from the School of Pharmaceutical Science at Peking University, Beijing, China, in 2019. He completed his Bachelor’s Degree in Pharmaceutical Sciences at the same institution in 2014.

🏢Work Experience:

Dr. Chong Qiu has been serving as an Associate Professor at the Artemisinin Research Center and the Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, since 2019. In addition to his role at the Research Center, he is an ongoing Young Scientist Board Member for the Asian Journal of Pharmaceutical Sciences, iMeta, and Traditional Medicine Research and Exploration

🏅Awards and Recognition:

Dr. Chong Qiu has an extensive publication record in high-impact journals, including notable works in Nature Communications and the Journal of Nanobiotechnology. His research has garnered significant recognition and has made substantial contributions to the fields of nanomedicine and drug delivery.

Publication Top Notes:

  • Photoaffinity Probe-Based Antimalarial Target Identification of Artemisinin in the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
  • Enhanced Tumor Penetration Across the Blood-Brain Barrier: Endoplasmic Reticulum Membrane Hybrid siRNA Nanoplexes
  • Advanced Strategies for Overcoming Endosomal/Lysosomal Barrier in Nanodrug Delivery
  • Advanced Strategies for Nucleic Acids and Small-Molecular Drugs in Combined Anticancer Therapy
  • Anemoside B4 Alleviates Neuropathic Pain Through Inhibiting Inflammation

 

 

 

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Posted on by ScienceFather

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Dr. Fernando Novio | Nanodrugs Awards | Best Researcher Award

Fernando Novio is an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB). Born on May 5th, 1976, he holds a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, and a Ph.D. in Chemistry from UAB (2007). His research expertise lies in the field of Inorganic Chemistry, with a focus on Bioinorganic and Nanomedicine. He has held postdoctoral positions at the Laboratoire de Chimie de Coordination in Toulouse and the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC). In December 2022, he secured a permanent position at UAB, where he leads a research group specializing in the development of nanostructured coordination polymers for therapeutic and diagnostic applications, particularly in brain diseases. Over his career, Novio has published 58 scientific papers, presented over 100 communications at conferences, and contributed to several European projects and patents. His work is widely recognized, with an h-index of 25 and approximately 1,400 citations. He has also been an editor of a scientific book and regularly reviews for prestigious journals.

Professional Profile:

Scopus

Google Scholar

Suitability Summary for Best Researcher Award:

Summary of Suitability: Dr. Fernando Novio is a highly qualified candidate for the Best Researcher Award, given his extensive academic background, research experience, and significant contributions to the fields of Inorganic Chemistry, Bioinorganic Chemistry, and Nanomedicine. His educational journey, beginning with a BSc in Chemistry (2000) and a Master’s degree (2002) from the University of Santiago de Compostela, culminated in a Ph.D. in Chemistry from Universitat Autónoma de Barcelona (UAB) in 2007. This strong foundation has enabled him to excel in his research career, particularly in developing coordination polymers for therapeutic and diagnostic applications, with a focus on brain diseases.

🎓Education:

Fernando Novio completed his BSc in Chemistry in 2000, followed by a Master’s degree in Chemistry in 2002, both from the University of Santiago de Compostela. He later pursued his Ph.D. in Chemistry at Universitat Autónoma de Barcelona (UAB), which he successfully completed in 2007.

🏢Work Experience:

After earning his Ph.D. in Chemistry, Fernando Novio undertook a postdoctoral position at the Laboratoire de Chimie de Coordination in Toulouse, France, where he worked from 2008 to 2011. He then continued his research as a postdoctoral researcher at the Catalan Institute of Nanoscience and Nanotechnology (ICN2-CSIC) in Barcelona, Spain, from 2011 to 2022. In December 2022, he was appointed as an Associate Professor in the Chemistry Department at Universitat Autónoma de Barcelona (UAB).

🏆Awards:

Fernando Novio has been honored with the Best Researcher Award at the International Research Awards, recognizing his significant contributions to the field. Additionally, he has received recognition for his work in Nanomedicine and Bioinorganic Chemistry, further highlighting his impact and achievements in these specialized areas of research.

Publication Top Notes:

  • Comparative study of frequency-dependent dielectric properties of ferrites MFe2O4 (M = Co, Mg, Cr and Mn) nanoparticles
    • Cited by: 58
  • NiFe2O4 nanoparticles/MWCNTs nanohybrid as anode material for lithium-ion battery
    • Cited by: 57
  • Nanohybrids of multi-walled carbon nanotubes and cobalt ferrite nanoparticles: High performance anode material for lithium-ion batteries
    • Cited by: 24
  • Nanocomposites of multi-walled carbon nanotubes/cobalt ferrite nanoparticles: synthesis, structural, dielectric and impedance spectroscopy
    • Cited by: 20
  • Annealing Induced Enhancement in Magnetic Properties of Co0.5Zn0.5Fe2O4 Nanoparticles
    • Cited by: 14

 

 

Mrs. María José Tapia | Nanobiotechnology Awards | Innovative Nanomaterials Research Award

Posted on by ScienceFather

Mrs. María José Tapia | Nanobiotechnology Awards | Innovative Nanomaterials Research Award

Mrs. María José Tapia , Laboratorio de Fisiología y Genética Marina , Chile

María José Tapia De la Jara, based in Coquimbo and available to relocate, is a dedicated marine biologist with extensive experience in research and community engagement. She holds a Marine Biology degree with distinction from Universidad Católica del Norte, Coquimbo, Chile, and has completed a student exchange program at Universidad Católica de Valencia, Spain. Her professional roles have included scientific monitoring and education at Proyecto Asociativo Regional Explora Coquimbo and Oceanogràfic de Valencia. María José has also worked as a research assistant at the Centro de Estudios Avanzados en Zonas Áridas, contributing to studies on protein extraction from fish and antimicrobial tests. She has been actively involved in raising environmental awareness through educational tours and traveling exhibits. Her certifications include PADI Open Water Diver and Deep Trekker Pilot ROV DTG3. Fluent in English and experienced with software like R and Microsoft Excel, María José combines her scientific expertise with strong communication skills to foster marine conservation and research.

Professional Profile:

orcid

 🎓Education:

María José Tapia De la Jara earned her Marine Biology degree with distinction from Universidad Católica del Norte in Coquimbo, Chile, where she studied from 2018 to 2024. As part of her education, she participated in a student exchange program at Universidad Católica de Valencia San Vicente Martir in Valencia, Spain, during 2023-2024. Her thesis focused on the characterization and analysis of the antibacterial capacity of protein extracts from the mucus of native marine fish Seriolella violacea, Cilus gilberti, and Seriola lalandi.

 🏢Work Experience:

María José Tapia De la Jara has accumulated extensive work experience in various roles. As a Scientific Monitor at Proyecto Asociativo Regional Explora Coquimbo from March 2018 to December 2020, she guided educational tours through the Faculty of Marine Sciences, the Mundo Mar Rescue Center, and the Aquarium and Museum of the University. She continued her role as a Scientific Monitor at Oceanogràfic de Valencia from January 2019 to December 2022, engaging the community with the marine environment and raising awareness through traveling exhibits addressing environmental issues and solutions. In October and November 2023, she worked as a Monitor of Attention and Logistics at Universidad Católica del Norte in Coquimbo.

Publication Top Notes:

Acciones por wrongful birth y wrongful life: ¿la vida como un perjuicio?

  • Author: María José Tapia
  • Source: Estudios de Derecho Privado. III Jornadas Nacionales de Profesoras de Derecho Privado
  • Year: 2023
  • Type: Book chapter (Writing – original draft)